On June 16, 2014, Waters Corporation (NYSE:WAT) unveiled Progenesis® QI for proteomics Version 2.0, the latest advance in proteomics data analysis software, which the company believes enables more rapid and reliable quantification and identification of differentially changing proteins in laboratory samples than ever before. The release of Progenesis QI for proteomics Version 2.0 expands Waters’® suite of focused, world-leading informatics packages for 'omics data analysis. The new features of Progenesis QI for proteomics Version 2.0 include Pathway Analysis, which aids the biological understanding of observed MS data; QC Metrics, which assesses LC-MS data quality to facilitate exclusion of sub-optimal measurements; and Process Automation, which eliminates the need to program repetitive steps to make analysis even faster. The new software now allows user-selectable HiN quantification of proteins, along with full HiN functionality for 2D-LC experiments. Progenesis QI for proteomics Version 2.0 takes ‘omics-based data analysis to the next level by enabling users to rapidly quantify and identify differences between protein samples. It provides an easy-to-learn, intuitive process based on how researchers work, a flexible workflow, and a highly visual interface to give the user confidence in their data. “Progenesis QI for proteomics Version 2.0 gives users more control and functionality than ever before. It solves a major bottleneck for biological research,” said Dr. Rohit Khanna, Vice President of Worldwide Marketing and Informatics for the Waters Division. “The expanded functionality has broad applications across proteomics research, health sciences, and food research.
Login Or Register To Read Full Story